The Framingham Risk Score Underestimates the Risk of Cardiovascular Events in the HER2-positive Breast Cancer Population

Current Oncology - Canada
doi 10.3747/co.24.3684
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Framingham Risk Score With Cardiovascular Events in Chronic Kidney Disease

PLoS ONE
Multidisciplinary
2013English

Framingham Score in the Evaluation of Cardiovascular Risk in Diabetics

Revista da Rede de Enfermagem do Nordeste
2014English

Adding Carotid Total Plaque Area to the Framingham Risk Score Improves Cardiovascular Risk Classification

Archives of Medical Science
Medicine
2016English

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

JAMA - Journal of the American Medical Association
Medicine
2008English

Using the Framingham Risk Score to Evaluate Immigrant Effect on Cardiovascular Disease Risk in Mexican Americans

Journal of Health Care for the Poor and Underserved
EnvironmentalPublic HealthOccupational Health
2012English

Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer

ESMO Open
Cancer ResearchOncology
2018English

Prediction of Coronary Heart Disease: A Comparison Between the Copenhagen Risk Score and the Framingham Risk Score Applied to a Dutch Population

Journal of Internal Medicine
Internal Medicine
2003English

Accurate Estimation of Cardiovascular Risk in a Non-Diabetic Adult: Detecting and Correcting the Error in the Reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial Population

BMJ Open
Medicine
2018English

Development of a Risk Scoring System for Evaluating the Prognosis of Patients With Her2-Positive Breast Cancer

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy